On August 1, 2024, AbbVie completed its $8.7 billion acquisition of Cerevel Therapeutics. The deal closed after a merger review by the U.S. Federal Trade Commission.
A Compass Lexecon team led…
On December 14, 2023, Pfizer completed its $43 billion acquisition of Seagen – the largest M&A deal in biopharma since 2019. The deal closed after merger reviews by competition authorities around…
Compass Lexecon worked closely with the merging parties on this matter, starting with a team advising Horizon on the merger (led by Compass Lexecon expert Mark Israel) and proceeding to the…
Learn how Compass Lexecon''s experts influenced the CRB to set fair royalty rates for mechanical licenses, including ringtones, benefiting Copyright Owners.
Compass Lexecon’s staff includes more than 850 employees, including professional consultants, analysts, and practice support personnel that span 23 offices across the globe.
